Regulators say there is no evidence that the milk poses a danger or that a live virus is present
Indian firm Panacea says aiming to make COVID-19 vaccine
Indian biotech firm Panacea Biotec Ltd said on Wednesday it would partner with US-based Refana Inc to make a potential vaccine for COVID-19.
Published : 10 June 2020, 06:06 AM
Updated : 10 June 2020, 06:06 AM
The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year, Panacea said in a statement to stock exchanges.
Panacea's shares jumped 20% in morning trading on India's National Stock Exchange after the news.
RELATED STORIES
Doctors demand arrest of those involved in recent attacks on two physicians in the district
At least seven people have died from suspected heatstroke in the country
Bangladesh has already seen five deaths from ‘heatstroke’ at the start of the summer
